Skip to main content

Evaluation and Management of Facial Palsy

  • Living reference work entry
  • First Online:
Albert and Jakobiec's Principles and Practice of Ophthalmology
  • 49 Accesses

Abstract

Facial paralysis afflicts a significant number of individuals annually. Although Bell’s palsy is the most common cause of facial paralysis, that diagnosis can be hastily made, and life-threatening conditions and appropriate treatments for other causes can be missed. Facial paralysis increases the risk of ocular damage and poor vision; hinders the ability to eat, drink, and speak effectively; and often results in a negative self-image. Aberrant nerve regeneration with facial spasm, synkinetic movement, and excessive tearing are long-term problems that also need to be managed.

Proper diagnosis, evaluation of the deficits with physical examination and imaging when needed, and instituting proper multidisciplinary management early in the disease process will optimize patient care and reduce the risk of permanent injury and deficits especially involving the eye. Although every practitioner will not be able to address all the issues involved with facial paralysis patients, understanding what treatments and interventions are available will facilitate appropriate and early referral to centers that can provide comprehensive care for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Holland NJ, Bernstein JM. Bell’s palsy. BMJ Clin Evid. 2014;2014:1204.

    PubMed  PubMed Central  Google Scholar 

  2. McCormick DP. Herpes-simplex virus as a cause of Bell's palsy. Lancet. 1972;1(7757):937–9.

    Article  CAS  PubMed  Google Scholar 

  3. Murakami S, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124(1 Pt 1):27–30.

    Article  CAS  PubMed  Google Scholar 

  4. Gary S, Remia P. Evidence-based guidelines update: Steroids and antivirals for Bell palsy. Report of the Subcommittee of the American Academy of Neurology. Neurology. 2012;79(22):2209-2213. https://doi.org/10.1212/WNL.0b13e31827978c.

  5. de Almeida JR, et al. Combined corticosteroid and antiviral treatment for bell palsy: a systematic review and meta-analysis. JAMA. 2009;302(9):985–93.

    Article  PubMed  Google Scholar 

  6. Sullivan FM, et al. A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell’s palsy: the BELLS study. Health Technol Assess. 2009;13(47):iii–iv, ix–xi, 1–130.

    Google Scholar 

  7. Engstrom M, et al. Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2008;7(11):993–1000.

    Article  PubMed  Google Scholar 

  8. Peitersen E. Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002;(549):4–30. PMID: 12482166.

    Google Scholar 

  9. Ikeda M, et al. Clinical factors that influence the prognosis of facial nerve paralysis and the magnitudes of influence. Laryngoscope. 2005;115(5):855–60.

    Article  PubMed  Google Scholar 

  10. Gilden DH. Clinical practice. Bell’s palsy. N Engl J Med. 2004;351(13):1323–31.

    Article  CAS  PubMed  Google Scholar 

  11. Phillips KM, et al. Onset of Bell’s palsy in late pregnancy and early puerperium is associated with worse long-term outcomes. Laryngoscope. 2017;127(12):2854–9.

    Article  CAS  PubMed  Google Scholar 

  12. Navarrete ML, et al. Recurrent Bell’s facial palsy: our experience. Acta Otorrinolaringol Esp. 2001;52(8):682–6.

    Article  CAS  PubMed  Google Scholar 

  13. Fujiwara T, et al. Prognostic factors of Bell's palsy: prospective patient collected observational study. Eur Arch Otorhinolaryngol. 2014;271(7):1891–5.

    Article  PubMed  Google Scholar 

  14. Baugh RF, et al. Clinical practice guideline: Bell’s palsy executive summary. Otolaryngol Head Neck Surg. 2013;149(5):656–63.

    Article  PubMed  Google Scholar 

  15. Revilla A. Differential diagnosis of tumor of the cerebellopontine recess. Bull Johns Hopkins Hosp. 1948;83:187–212.

    Google Scholar 

  16. Cushing H. Tumors of the nervus acousticus and the syndrome of the cerebellopontine angle. Philadelphia: WB Saunders Company; 1917.

    Google Scholar 

  17. Nguyen J-P, Bendib B, Lacombe H, Keravel Y, Brugières P, Gray F. Intracranial neuromas [French]. In: Neurologie. Paris: Elsevier; 2006.

    Google Scholar 

  18. Kunert P, Smolarek B, Marchel A. Facial nerve damage following surgery for cerebellopontine angle tumours. Prevention and comprehensive treatment. Neurol Neurochir Pol. 2011;45(5):480–8.

    Article  PubMed  Google Scholar 

  19. Hohman MH, Hadlock TA. Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center. Laryngoscope. 2014;124(7):E283–93.

    Article  PubMed  Google Scholar 

  20. Rinaldi V, et al. Facial nerve outcome after vestibular schwannoma surgery: our experience. J Neurol Surg B Skull Base. 2012;73(1):21–7.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Albathi M, et al. Early nerve grafting for facial paralysis after cerebellopontine angle tumor resection with preserved facial nerve continuity. JAMA Facial Plast Surg. 2016;18(1):54–60.

    Article  PubMed  Google Scholar 

  22. Jacob JT, Driscoll CL, Link MJ. Facial nerve schwannomas of the cerebellopontine angle: the mayo clinic experience. J Neurol Surg B Skull Base. 2012;73(4):230–5.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Jackson CG, et al. Facial paralysis of neoplastic origin: diagnosis and management. Laryngoscope. 1980;90(10 Pt 1):1581–95.

    CAS  PubMed  Google Scholar 

  24. Leonetti JP, et al. Neoplastic causes of nonacute facial paralysis: a review of 221 cases. Ear Nose Throat J. 2016;95(9):390–404.

    Article  PubMed  Google Scholar 

  25. Bron LP, et al. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope. 2003;113(6):1070–5.

    Article  PubMed  Google Scholar 

  26. Saia V, Pantoni L. Progressive stroke in pontine infarction. Acta Neurol Scand. 2009;120(4):213–5.

    Article  CAS  PubMed  Google Scholar 

  27. Bassetti C, et al. Isolated infarcts of the pons. Neurology. 1996;46(1):165–75.

    Article  CAS  PubMed  Google Scholar 

  28. Oppenheim C, et al. False-negative diffusion-weighted MR findings in acute ischemic stroke. AJNR Am J Neuroradiol. 2000;21(8):1434–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Murakami S, et al. Treatment of Ramsay hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol. 1997;41(3):353–7.

    Article  CAS  PubMed  Google Scholar 

  30. Aleksic SN, Budzilovich GN, Lieberman AN. Herpes zoster oticus and facial paralysis (Ramsay Hunt syndrome). Clinico-pathologic study and review of literature. J Neurol Sci. 1973;20(2):149–59.

    Article  CAS  PubMed  Google Scholar 

  31. Jonsson L, et al. Gd-DPTA enhanced MRI in Bell’s palsy and herpes zoster oticus: an overview and implications for future studies. Acta Otolaryngol. 1995;115(5):577–84.

    Article  CAS  PubMed  Google Scholar 

  32. Uri N, et al. Acyclovir in the treatment of Ramsay Hunt syndrome. Otolaryngol Head Neck Surg. 2003;129(4):379–81.

    Article  PubMed  Google Scholar 

  33. Kuehn BM. CDC estimates 300,000 US cases of Lyme disease annually. JAMA. 2013;310(11):1110.

    Article  CAS  PubMed  Google Scholar 

  34. Cooper L, et al. Lyme disease and Bell’s palsy: an epidemiological study of diagnosis and risk in England. Br J Gen Pract. 2017;67(658):e329–35.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Jowett N, et al. Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes. Laryngoscope. 2017;127(6):1451–8.

    Article  CAS  PubMed  Google Scholar 

  36. Joseph EM, Sperling NM. Facial nerve paralysis in acute otitis media: cause and management revisited. Otolaryngol Head Neck Surg. 1998;118(5):694–6.

    CAS  PubMed  Google Scholar 

  37. Kangsanarak J, et al. Extracranial and intracranial complications of suppurative otitis media. Report of 102 cases. J Laryngol Otol. 1993;107(11):999–1004.

    Article  CAS  PubMed  Google Scholar 

  38. Ellefsen B, Bonding P. Facial palsy in acute otitis media. Clin Otolaryngol Allied Sci. 1996;21(5):393–5.

    Article  CAS  PubMed  Google Scholar 

  39. Yetiser S, Tosun F, Kazkayasi M. Facial nerve paralysis due to chronic otitis media. Otol Neurotol. 2002;23(4):580–8.

    Article  PubMed  Google Scholar 

  40. Redaelli de Zinis LO, Gamba P, Balzanelli C. Acute otitis media and facial nerve paralysis in adults. Otol Neurotol. 2003;24(1):113–7.

    Article  PubMed  Google Scholar 

  41. Montava M, et al. Temporal bone fracture under lateral impact: biomechanical and macroscopic evaluation. Med Biol Eng Comput. 2016;54(2–3):351–60.

    Article  PubMed  Google Scholar 

  42. Lydiatt DD. Medical malpractice and facial nerve paralysis. Arch Otolaryngol Head Neck Surg. 2003;129(1):50–3.

    Article  PubMed  Google Scholar 

  43. Falco NA, Eriksson E. Facial nerve palsy in the newborn: incidence and outcome. Plast Reconstr Surg. 1990;85(1):1–4.

    Article  CAS  PubMed  Google Scholar 

  44. Bergman I, et al. Management of facial palsy caused by birth trauma. Laryngoscope. 1986;96(4):381–4.

    Article  CAS  PubMed  Google Scholar 

  45. Zuker RSaRM. Congenital facial weakness. In: Azizzadeh WHSaB, editor. Facial nerve. Stuttgart: Thieme Medical Published; 2014.

    Google Scholar 

  46. Kaur R, Morris M, Pichichero ME. Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era. Pediatrics. 2017;140(3):18.

    Article  Google Scholar 

  47. Gaio E, et al. Facial nerve paralysis secondary to acute otitis media in infants and children. J Paediatr Child Health. 2004;40(8):483–6.

    Article  CAS  PubMed  Google Scholar 

  48. Tveitnes D, Oymar K, Natas O. Acute facial nerve palsy in children: how often is it Lyme borreliosis? Scand J Infect Dis. 2007;39(5):425–31.

    Article  PubMed  Google Scholar 

  49. Ujma B, Krzystanek W, Roznatowska A. Melkersson-Rosenthal syndrom (author’s transl). Przegl Lek. 1980;37(10):719–20.

    CAS  PubMed  Google Scholar 

  50. Gaudin RA, et al. Bilateral facial paralysis: a 13-year experience. Plast Reconstr Surg. 2016;138(4):879–87.

    Article  CAS  PubMed  Google Scholar 

  51. Evans DG. Neurofibromatosis type 2. Handb Clin Neurol. 2015;132:87–96.

    Article  CAS  PubMed  Google Scholar 

  52. Sejvar JJ, et al. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.

    Article  PubMed  Google Scholar 

  53. Bhargava A, et al. A study of Guillain-Barre syndrome with reference to cranial neuropathy and its prognostic implication. J Neurosci Rural Pract. 2014;5(Suppl 1):S43–7.

    PubMed  PubMed Central  Google Scholar 

  54. Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry. 1988;51(5):605–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Hoyle JC, Jablonski C, Newton HB. Neurosarcoidosis: clinical review of a disorder with challenging inpatient presentations and diagnostic considerations. Neurohospitalist. 2014;4(2):94–101.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Homer N, Fay A. Management of long-standing flaccid facial palsy: periocular considerations. Otolaryngol Clin N Am. 2018;51(6):1107–18. https://doi.org/10.1016/j.otc.2018.07.007. Epub 2018 Aug 28

    Article  Google Scholar 

  57. Ziahosseini K, Nduka C, Malhotra R. Ophthalmic grading of facial paralysis: need for a closer look. Br J Ophthalmol. 2015;99(9):1171–5. https://doi.org/10.1136/bjophthalmol-2014-305716. Epub 2015 Jan 6

    Article  PubMed  Google Scholar 

  58. Bhama PK, Hadlock TA. Contemporary facial reanimation. Facial Plast Surg. 2014;30(2):145–51. https://doi.org/10.1055/s-0034-1371900. Epub 2014 May 8

    Article  CAS  PubMed  Google Scholar 

  59. Custer PL. Ophthalmic management of the facial palsy patient. Semin Plast Surg. 2004;18(1):31–8. https://doi.org/10.1055/s-2004-823121.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Allen RC. Controversies in periocular reconstruction for facial nerve palsy. Curr Opin Ophthalmol. 2018;29(5):423–7. https://doi.org/10.1097/ICU.0000000000000510.

    Article  PubMed  Google Scholar 

  61. Henstrom DK, Lindsay RW, Cheney ML, Hadlock TA. Surgical treatment of the periocular complex and improvement of quality of life in patients with facial paralysis. Arch Facial Plast Surg. 2011;13(2):125–8. https://doi.org/10.1001/archfacial.2011.9.

    Article  PubMed  Google Scholar 

  62. Golio D, De Martelaere S, Anderson J, Esmaeli B. Outcomes of periocular reconstruction for facial nerve paralysis in cancer patients. Plast Reconstr Surg. 2007;119(4):1233–7.

    Article  CAS  PubMed  Google Scholar 

  63. Joseph SS, Joseph AW, Douglas RS, Massry GG. Periocular reconstruction in patients with facial paralysis. Otolaryngol Clin N Am. 2016;49(2):475–87. https://doi.org/10.1016/j.otc.2015.10.011.

    Article  Google Scholar 

  64. Maqsood SE, Cascone N, Grixti A, Kannan R, Nduka C, Malhotra R. Functional and aesthetic outcomes of eyelid skin grafting in facial nerve palsy. Br J Ophthalmol. 2018; https://doi.org/10.1136/bjophthalmol-2018-312311. pii: bjophthalmol-2018-312311. [Epub ahead of print].

  65. Tan ST, Staiano JJ, Itinteang T, McIntyre BC, MacKinnon CA, Glasson DW. Gold weight implantation and lateral tarsorrhaphy for upper eyelid paralysis. J Craniomaxillofac Surg. 2013;41(3):e49–53. https://doi.org/10.1016/j.jcms.2012.07.015. Epub 2012 Aug 14

    Article  PubMed  Google Scholar 

  66. Bran GM, Börjesson PK, Boahene KD, Gosepath J, Lohuis PJ. Effect of endoscopic brow lift on contractures and synkinesis of the facial muscles in patients with a regenerated postparalytic facial nerve syndrome. Plast Reconstr Surg. 2014;133(1):121–9. https://doi.org/10.1097/01.prs.0000436834.19066.7c.

    Article  CAS  PubMed  Google Scholar 

  67. Siah WF, Nagendran S, Tan P, Ali Ahmad SM, Litwin AS, Malhotra R. Late outcomes of gold weights and platinum chains for upper eyelid loading. Br J Ophthalmol. 2018;102(2):164–8. https://doi.org/10.1136/bjophthalmol-2016-310089. Epub 2017 Jul 8.

    Article  PubMed  Google Scholar 

  68. Malik A, Joshi N. Gold in the balance: how does patient posture affect eyelid closure? Orbit. 2017;36(5):347–9. https://doi.org/10.1080/01676830.2017.1337176. Epub 2017 Jul 5

    Article  PubMed  Google Scholar 

  69. Wagh VK, Lim WS, Cascone NC, Morley AM. Post-septal upper eyelid loading for treatment of exposure keratopathy secondary to non-cicatricial lagophthalmos. Orbit. 2016;35(5):239–44. https://doi.org/10.1080/01676830.2016.1176213. Epub 2016 Aug 10

    Article  PubMed  Google Scholar 

  70. Rozen S, Lehrman C. Upper eyelid postseptal weight placement for treatment of paralytic lagophthalmos. Plast Reconstr Surg. 2013;131(6):1253–65. https://doi.org/10.1097/PRS.0b013e31828be961.

    Article  CAS  PubMed  Google Scholar 

  71. Mavrikakis I, Beckingsale P, Lee E, Riaz Y, Brittain P. Changes in corneal topography with upper eyelid gold weight implants. Ophthalmic Plast Reconstr Surg. 2006;22(5):331–4.

    Article  PubMed  Google Scholar 

  72. Salloum G, Carruth BP, Hill RH 3rd, Czyz CN, Bersani TA. Transitioning from a gold weight to an “enhanced” palpebral spring in the management of paralytic lagophthalmos secondary to facial nerve palsy. Orbit. 2019;38(2):119–23. https://doi.org/10.1080/01676830.2018.1497067. Epub 2018 Jul 26

    Article  PubMed  Google Scholar 

  73. Sales-Sanz M, Barrancos C, Won-Kim HR, Sales-Sanz A, Colmenero C. Reconstructive sbperiosteal midface lift: a three nonvisible incision approach. Orbit. 2017;36(5):256–63. https://doi.org/10.1080/01676830.2017.1337166. Epub 2017 Jul 5

    Article  PubMed  Google Scholar 

  74. Pascali M, Botti C, Cervelli V, Botti G. Vertical midface lifting with periorbital anchoring in the management of lower eyelid retraction: a 10-year clinical retrospective study. Plast Reconstr Surg. 2017;140(1):33–45. https://doi.org/10.1097/PRS.0000000000003452.

    Article  CAS  PubMed  Google Scholar 

  75. Compton CJ, Clark JD, Nunery WR, Lee HB. Recession and extirpation of the lower eyelid retractors for paralytic Lagophthalmos. Ophthalmic Plast Reconstr Surg. 2015;31(4):323–4. https://doi.org/10.1097/IOP.0000000000000485.

    Article  PubMed  Google Scholar 

  76. Iyengar SS, Burnstine MA. Treatment of symptomatic facial nerve paralysis with lower eyelid fascia lata suspension. Plast Reconstr Surg. 2012;129(3):569e–71e. https://doi.org/10.1097/PRS.0b013e3182419d4b.

    Article  CAS  PubMed  Google Scholar 

  77. Elner VM, Mauffray RO, Fante RG, Harris M, Morton AD, Hassan AS. Comprehensive midfacial elevation for ocular complications of facial nerve palsy. Arch Facial Plast Surg. 2003;5(5):427–33.

    Article  PubMed  Google Scholar 

  78. Alford EL. The SOOF lift as an adjunct in rehabilitation of facial paralysis: help or hype? Facial Plast Surg. 2000;16(4):345–9.

    Article  CAS  PubMed  Google Scholar 

  79. Dedhia R, Hsieh TY, Chin O, Shipchandler TZ, Tollefson TT. Outcomes from lateral eyelid coupling for facial paralysis using the modified Tarsoconjunctival flap. JAMA Facial Plast Surg. 2018;20(5):381–6. https://doi.org/10.1001/jamafacial.2018.0070.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Guelinckx PJ. Blink restoration in long-standing facial paralysis: use of free neurovascular platysma transfer. Plast Reconstr Surg Glob Open. 2018;6(10):e1939. https://doi.org/10.1097/GOX.0000000000001939. eCollection 2018 Oct

    Article  PubMed  PubMed Central  Google Scholar 

  81. Roggenkämper P, Laskawi R, Damenz W, Schröder M, Nüssgens Z. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin. Doc Ophthalmol. 1994;86(4):395–402.

    Article  PubMed  Google Scholar 

  82. Simpson LL. Identification of the major steps in botulinum toxin action. Ann Rev Pharmacol Toxicol. 2004;44:167–93. https://doi.org/10.1146/annurev.pharmtox.44.101802.121554.

    Article  CAS  Google Scholar 

  83. van Veen MM, Dusseldorp JR, Hadlock TA. Long-term outcome of selective neurectomy for refractory periocular synkinesis. Laryngoscope. 2018;128(10):2291–5. PMID: 29668050. https://doi.org/10.1002/lary.27225. Epub 2018 Apr 18

  84. Loyo M, Jones D, Lee LN, Collar RM, Molendijk J, Boahene KD, Ishii LE, Byrne PJ. Treatment of the periocular complex in paralytic lagophthalmos. Ann Otol Rhinol Laryngol. 2015;124(4):273–9. https://doi.org/10.1177/0003489414560584. Epub 2014 Dec 4

    Article  PubMed  Google Scholar 

  85. Lindsay RW, et al. Correction of the nasal base in the flaccidly paralyzed face: an orphaned problem in facial paralysis. Plast Reconstr Surg. 2010;126(4):185e–6e.

    Article  PubMed  CAS  Google Scholar 

  86. Joseph AW, Kim JC. Management of flaccid facial paralysis of less than two years’ duration. Otolaryngol Clin N Am. 2018;51(6):1093–105.

    Article  Google Scholar 

  87. Salmeron-Gonzalez E, et al. Masseter-to-facial nerve transfer for reanimation of a patient with long-term facial paralysis. J Craniofac Surg. 2019;30(1):e43–5.

    Article  PubMed  Google Scholar 

  88. Mohanty AJ, et al. Reuse of the Masseteric nerve for dynamic reanimation in facial palsy patients with previously failed one-stage dynamic smile reanimation. Plast Reconstr Surg. 2019;143(2):567–71.

    Article  CAS  PubMed  Google Scholar 

  89. Zhang S, et al. Early Masseter to facial nerve transfer may improve smile excursion in facial paralysis. Plast Reconstr Surg Glob Open. 2018;6(11):e2023.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Murphey AW, Clinkscales WB, Oyer SL. Masseteric Nerve transfer for facial Nerve paralysis: a systematic review and meta-analysis. JAMA Facial Plast Surg. 2018;20(2):104–10.

    Article  PubMed  Google Scholar 

  91. Godefroy WP, et al. Intratemporal facial nerve transfer with direct coaptation to the hypoglossal nerve. Otol Neurotol. 2007;28(4):546–50.

    Article  PubMed  Google Scholar 

  92. Owusu JA, Truong L, Kim JC. Facial nerve reconstruction with concurrent Masseteric nerve transfer and cable grafting. JAMA Facial Plast Surg. 2016;18(5):335–9.

    Article  PubMed  Google Scholar 

  93. Jowett N, et al. Toward the bionic face: a novel neuroprosthetic device paradigm for facial reanimation consisting of neural blockade and functional electrical stimulation. Plast Reconstr Surg. 2019;143(1):62e–76e.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Skourtis ME, et al. Immediate Gore-Tex sling suspension for management of facial paralysis in head and neck extirpative surgery. Otolaryngol Head Neck Surg. 2007;137(2):228–32.

    Article  PubMed  Google Scholar 

  95. Garcia RM, et al. Contemporary solutions for the treatment of facial nerve paralysis. Plast Reconstr Surg. 2015;135(6):1025e–46e.

    Article  CAS  PubMed  Google Scholar 

  96. Labbe D, Huault M. Lengthening temporalis myoplasty and lip reanimation. Plast Reconstr Surg. 2000;105(4):1289–97; discussion 1298

    Article  CAS  PubMed  Google Scholar 

  97. Byrne PJ, et al. Temporalis tendon transfer as part of a comprehensive approach to facial reanimation. Arch Facial Plast Surg. 2007;9(4):234–41.

    Article  PubMed  Google Scholar 

  98. Lindsay RW, et al. A systematic algorithm for the management of lower lip asymmetry. Am J Otolaryngol. 2011;32(1):1–7.

    Article  PubMed  Google Scholar 

  99. Oyer SL, et al. Comparison of objective outcomes in dynamic lower facial reanimation with temporalis tendon and Gracilis free muscle transfer. JAMA Otolaryngol Head Neck Surg. 2018;44:1162–8.

    Article  Google Scholar 

  100. Chuang DC, et al. Comparison of functional results after cross-face nerve graft-, spinal accessory nerve-, and Masseter nerve-innervated Gracilis for facial paralysis reconstruction: the Chang Gung experience. Ann Plast Surg. 2018;81.(6S Suppl 1:S21–9.

    Article  CAS  PubMed  Google Scholar 

  101. Boahene KO, et al. The multivector Gracilis free functional muscle flap for facial reanimation. JAMA Facial Plast Surg. 2018;20(4):300–6.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Bhama PK, et al. Objective outcomes analysis following microvascular Gracilis transfer for facial reanimation: a review of 10 years’ experience. JAMA Facial Plast Surg. 2014;16(2):85–92.

    Article  PubMed  Google Scholar 

  103. Harii K, et al. One-stage transfer of the latissimus Dorsi muscle for reanimation of a paralyzed face: a new alternative. Plast Reconstr Surg. 1998;102(4):941–51.

    Article  CAS  PubMed  Google Scholar 

  104. Takushima A, et al. Neurovascular free-muscle transfer for the treatment of established facial paralysis following ablative surgery in the parotid region. Plast Reconstr Surg. 2004;113(6):1563–72.

    Article  PubMed  Google Scholar 

  105. Jowett N, Hadlock TA. Free Gracilis transfer and static facial suspension for midfacial reanimation in long-standing flaccid facial palsy. Otolaryngol Clin N Am. 2018;51(6):1129–39.

    Article  Google Scholar 

  106. Henstrom DK, et al. Platysmectomy: an effective intervention for facial synkinesis and hypertonicity. Arch Facial Plast Surg. 2011;13(4):239–43.

    Article  PubMed  Google Scholar 

  107. Azizzadeh B, et al. Modified selective neurectomy for the treatment of post-facial paralysis synkinesis. Plast Reconstr Surg. 2019;143(5):1483–96.

    Article  CAS  PubMed  Google Scholar 

  108. Ridley F. Therapeutic uses of scleral contact lenses. Int Ophthalmol Clin. 1962;2:687–716.

    Article  CAS  PubMed  Google Scholar 

  109. Tan DTH, Pullum KW, Buckley RJ. Medical applications of scleral contact lenses, 2: gas permeable scleral contact lenses. Cornea. 1995;14:130–7.

    Article  CAS  PubMed  Google Scholar 

  110. Grey F, Carley F, Biswas S, Tromans C. Scleral contact lens management of bilateral exposure and neutrophic keratopathy. Cont Lens Anterior Eye. 2012;35:288–91.

    Article  PubMed  Google Scholar 

  111. Harthan JS, Shorter E. Therapeutic uses of scleral contact lenses for ocular surface disease: patient selection and special considerations. Clin Optom. 2018;10:65–74.

    Article  Google Scholar 

  112. Rosenthal P, Croteau A. Fluid-ventilated, gas permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Eye Contact Lens. 2005;31(1):130–4.

    Article  PubMed  Google Scholar 

  113. Schornack MM. Scleral lenses: a literature review. Eye Contact Lens. 2015;41:3–11.

    Article  PubMed  Google Scholar 

  114. Pullum KW, Stapleton FJ. Scleral lens induced corneal swelling: what is the effect of varying Dk and lens thickness? CLAO J. 1997;23:259–63.

    CAS  PubMed  Google Scholar 

  115. Giasson CJ, Morency J, Melillo M, Michaud L. Oxygen tension beneath scleral lenses of different clearances. Optom Vis Sci. 2017;94:466–75.

    Article  PubMed  Google Scholar 

  116. Walker MK, Bergmanson JP, Miller WL, Marsack JD, Johnson LA. Complications and fitting challenges associated with scleral contact lenses: a review. Cont Lens Anterior Eye. 2016;39:88–96.

    Article  PubMed  Google Scholar 

  117. Robinson MW, Baiungo J. Facial rehabilitation: evaluation and treatment strategies for patients with facial palsy. Otolarynogol Clin North Am. 2018;51:1151–67.

    Article  Google Scholar 

  118. Ross BG, Fradet G, Nedzelski JM. Developments of a sensistive clinical facial grading system. Otolaryngol Head Neck Surg. 1996;111(3):380–6.

    Article  Google Scholar 

  119. Banks CA, Bhama PK, et al. Clinician-graded electronic facial paralysis assessment: the eFACE. Plast Reconstr Surg. 2015;136(2):223–30.

    Article  CAS  Google Scholar 

  120. Kahn JH, Ngo RYS. Validation of a patient-graded instrument of facial nerve paralysis: the FaCE scale. Larynogoscope. 2001;123(5):387–98.

    Google Scholar 

  121. Coulson SE, O’dwer NJ, et al. Expression of emotion and quality of life after facial nerve paralysis. Otol Neurotol. 2004;25(6):1014–9.

    Article  PubMed  Google Scholar 

  122. VanSwearingen JM, Brach JS. The facial disability index: reliability and validity of a disability assessment instrument for disorders of the facial neuromuscular system. Phys Ther. 1996;76(12):1288–98, 300.

    Article  CAS  PubMed  Google Scholar 

  123. VanSweringen JM. Facial rehabilitation: a neuromuscular reeducation, patient-centered approach. Facial Plast Surg. 2008;24(2):250–9.

    Article  CAS  Google Scholar 

  124. Brach JS, VanSwearingen J. Physical therapy for facial paralysis: a tailored treatment approach. Phys Ther. 1999;79:397–404.

    Article  CAS  PubMed  Google Scholar 

  125. Tuncay F, Borman P, et al. Role of electrical stimulation added to conventional therapy in patients with idiopathic facial (Bell) palsy. Am J Phys Med Rehabil. 2015;94(3):222–8.

    Article  PubMed  Google Scholar 

  126. Hyvarinen A, Tarkka I, et al. Cutaneous electrical stimulation treatment in unresolved facial nerve paralysis. Am J Phys Med Rehabil. 2008;87(12):992–7.

    Article  PubMed  Google Scholar 

  127. Fuiwara K, Furuta Y, et al. Factors affecting the effect of physical rehabilitation therapy for synkinesis as a sequela to facial nerve palsy. Auris Nasus Larynx. 2017;45:732–9.

    Article  Google Scholar 

  128. Fuiwara K, Furuta Y, et al. Comparison of facial synkinesis at 6 and 12 months after the onset of peripheral facial palsy. Auris Nasus Larynx. 2015;42:271–4.

    Article  Google Scholar 

  129. Lee JM, Choi KH, et al. Half-mirror biofeedback exercise in combination with three botulinum toxin a injections for long-lasting treatment of facial sequelae after facial paralysis. J Plast Reconstr Aesthet Surg. 2015;68:71–8.

    Article  PubMed  Google Scholar 

  130. Allison Munn, Michelle Cameron, Myriam Loyo. Trends in Electric Stimulation for Facial Paralysis: Electronic Survey of Physical Therapists in Oregon. Archives of Physiotherapy and Rehabilitation 3 (2020):001–008.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John D. Ng .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Loyo, M., Ng, J.D., Louie, D., McReynolds, M. (2020). Evaluation and Management of Facial Palsy. In: Albert, D., Miller, J., Azar, D., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-90495-5_88-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90495-5_88-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90495-5

  • Online ISBN: 978-3-319-90495-5

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics